Historical record - last NADAC effective date: 8/18/2021
Product Information
OLOPATADINE HCL 0.2% EYE DROP is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $4.2477 per ML under NDC 62332050203. Its NADAC has been published 71 times since Apr 29, 2020.
FDA first approved this application on Apr 29, 2019.
Strength
2 mg/mL
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332050203
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
8/18/2021
Active Ingredients
OLOPATADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209420FDA Approved
4/29/2019
On Market Since
4/29/2019
Pharmacological Classes
Price Statistics
The NADAC for OLOPATADINE HCL 0.2% EYE DROP has been published 71 times since Apr 29, 2020, and over the history we have for it it has declined 26.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.2477 per ML |
|---|---|
| All-time high | $5.8621 (Jul 14, 2021) |
| All-time low | $4.2477 (Aug 18, 2021) |
| Median price | $5.0379 |
| Average price | $5.0475 |
| Largest weekly change | -26.6% (Jul 21, 2021) |
| Weeks tracked | 71 |
| Tracking since | Apr 29, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
0.0%
All
-26.8%
Last surveyed Sep 1, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the olopatadine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OLOPATADINE HCL 0.2% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for OLOPATADINE HCL 0.2% EYE DROP, manufactured by Alembic Pharmaceuticals Inc., is $4.2477 per ML (NDC 62332050203), effective Sep 1, 2021.
How has the price of OLOPATADINE HCL 0.2% EYE DROP changed over time?
Over the history we have for it, the NADAC for OLOPATADINE HCL 0.2% EYE DROP has declined 26.8%. It has been tracked across 71 weekly CMS publications since Apr 29, 2020.
What are the highest and lowest recorded NADAC prices for OLOPATADINE HCL 0.2% EYE DROP?
Since Apr 29, 2020, the NADAC for OLOPATADINE HCL 0.2% EYE DROP has ranged from a low of $4.2477 (Aug 18, 2021) to a high of $5.8621 (Jul 14, 2021), with a median of $5.0379 per ML.
Are there cheaper alternatives to OLOPATADINE HCL 0.2% EYE DROP?
No other NADAC-published product currently shares the active ingredient and strength of OLOPATADINE HCL 0.2% EYE DROP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OLOPATADINE HCL 0.2% EYE DROP?
OLOPATADINE HCL 0.2% EYE DROP (NDC 62332050203) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.